Acrowell Labs Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 30-10-2024
- Paid Up Capital ₹ 1.50 M
as on 30-10-2024
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 30-10-2024
- Revenue 53896.49%
(FY 2023)
- Profit -443.62%
(FY 2023)
- Ebitda -469.20%
(FY 2023)
- Net Worth -398.17%
(FY 2023)
- Total Assets 105.35%
(FY 2023)
About Acrowell Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹3.00 M.
Arjun Garg, Sanjay Garg, and Alka Garg serve as directors at the Company.
- CIN/LLPIN
U74999HR2022PTC100296
- Company No.
100296
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Kurukshetra, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Acrowell Labs Private Limited offer?
Acrowell Labs Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Common Disease Medicines, Allopathic Cough Syrup, TB, Tumor & Cancer Drugs, Anti Cancer Medicines.
Who are the key members and board of directors at Acrowell Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Garg  | Director | 03-Jan-2022 | Current |
| Sanjay Garg | Director | 03-Jan-2022 | Current |
| Alka Garg | Director | 15-Jan-2024 | Current |
Financial Performance of Acrowell Labs.
Acrowell Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53896.49% increase. The company also saw a substantial fall in profitability, with a 443.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 398.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acrowell Labs?
Unlock access to Acrowell Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Arjun Buildtech Private LimitedActive 15 years 8 monthsArjun Garg and Sanjay Garg are mutual person
- Shitiz Agrotech Private LimitedActive 13 years 5 months
Arjun Garg and Sanjay Garg are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 11 Jul 2023 | ₹3.00 M | Open |
How Many Employees Work at Acrowell Labs?
Acrowell Labs has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acrowell Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acrowell Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
